NVR CLL (Tekturna HCT 150 mg-25 mg)
Generic Name: aliskiren/hydrochlorothiazide
Pill imprint NVR CLL has been identified as Tekturna HCT 150 mg-25 mg.
Tekturna HCT is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Tekturna HCT 150 mg-25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- NVR CLL
- 150 mg-25 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Miscellaneous antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide red
Note: Inactive ingredients may vary.
More about Tekturna HCT (aliskiren / hydrochlorothiazide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 4 Reviews – Add your own review/rating
- Drug class: miscellaneous antihypertensive combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.